Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702113 · ClinicalTrials.gov registry record · NA
Evaluating Pharmacogenomic Variants for Cardiology Therapeutics
A NA study, sponsored by Cipherome.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT04702113 is a NA study that has completed, run by Cipherome. The registered enrollment target is 300 participants.
The verdict
NCT04702113, a NA study, has completed, sponsored by Cipherome.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
Cipherome's Lighthouse is a clinical decision support tool that incorporates a patient's pharmacogenetic information to determine therapeutic strategy, including determining appropriate dosage or assessing the likelihood of toxicity of a therapeutic regimen.
Interventions
- DIAGNOSTIC_TEST Cipherome Lighthouse Pilot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-12-03 |
| Est. Completion | 2023-07-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04702113
The ClinicalTrials.gov registry entry for NCT04702113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cipherome, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cipherome Lighthouse Pilot is the first listed.
NCT04702113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04702113 about?
NCT04702113 is a clinical study titled "Evaluating Pharmacogenomic Variants for Cardiology Therapeutics". Cipherome's Lighthouse is a clinical decision support tool that incorporates a patient's pharmacogenetic information to determine therapeutic strategy, including determining appropriate dosage or assessing the likelihood of toxicity of a therapeutic regimen.
What is the current status of trial NCT04702113?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2020-12-03. Estimated completion is 2023-07-27.
What interventions are being tested in trial NCT04702113?
The interventions under investigation include: Cipherome Lighthouse Pilot (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04702113?
This trial is sponsored by Cipherome, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.